We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oncolytics Meets Primary Endpoint for First Stage of U.S. Phase 2 SCLC Clinical Trial

News   Feb 01, 2013

 
Oncolytics Meets Primary Endpoint for First Stage of U.S. Phase 2 SCLC Clinical Trial
 
 
 

RELATED ARTICLES

Powerful Microscope Reveals Motility Nanoscaffold

News

Using one of the most powerful microscopes in the world, scientists have identified a dense, dynamic and disorganized actin filament nanoscaffold that is induced in response to a molecular signal.

READ MORE

Targeting Tumor-infiltrating Immune Cells to Get Them to Fight

News

A team of Vanderbilt University bioengineers designed a nanoscale particle that targets tumor-infiltrating immune cells, flipping on a switch that tells them to start fighting.

READ MORE

Are You A Super Pooper?

News

Fecal ‘super-donors’ can provide the necessary bacteria to restore gut chemicals that are lacking in illnesses like IBD and diabetes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE